Tetrazine-trans-cyclooctene ligation for the rapid construction of integrin αvβ3 targeted PET tracer based on a cyclic RGD peptide
- 1 September 2011
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (17), 5011-5014
- https://doi.org/10.1016/j.bmcl.2011.04.116
Abstract
No abstract availableKeywords
Funding Information
- NIH (P20 RR017716)
- COBRE Program of the NCRR (P30CA014089)
- National Cancer Institute, research (DE-SC0002353)
- NSF CRIF:MU (CHE 0840401, CHE-0541775)
This publication has 32 references indexed in Scilit:
- High‐Yielding, Two‐Step 18F Labeling Strategy for 18F‐PARP1 InhibitorsChemMedChem, 2011
- Tetrazine–trans-cyclooctene ligation for the rapid construction of 18F labeled probesChemical Communications, 2010
- In Vivo Chemistry for Pretargeted Tumor Imaging in Live MiceAngewandte Chemie-International Edition, 2010
- Tetrazine-Based Cycloadditions: Application to Pretargeted Live Cell ImagingBioconjugate Chemistry, 2008
- Radiolabeling of HER2-specific Affibody® molecule with F-18Journal of Fluorine Chemistry, 2008
- Tetrazine Ligation: Fast Bioconjugation Based on Inverse-Electron-Demand Diels−Alder ReactivityJournal of the American Chemical Society, 2008
- Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGDPLoS Medicine, 2005
- Molecular Imaging: Looking at Problems, Seeing SolutionsScience, 2003
- What does positron emission tomography offer oncology?European Journal Of Cancer, 2000
- Integrin SignalingScience, 1999